Acumen Pharmaceuticals, Inc.
Institutional holders · 13F as of Mar 31, 2026
| Holder | Value | % of shares |
|---|---|---|
| MARSHALL WACE, LLP | $455.2K | 0.27% |
| BANK OF AMERICA CORP /DE | $506.7K | 0.33% |
| Ikarian Capital, LLC | $536.6K | 0.35% |
| Citadel Advisors LLC | $728.5K | 0.48% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $787.4K | 0.52% |
| TWO SIGMA ADVISERS, LP | $890.0K | 0.58% |
| GEODE CAPITAL MANAGEMENT, LLC | $982.8K | 0.58% |
| Renaissance Technologies LLC | $1.12M | 0.66% |
| Laurion Capital Management LP | $1.24M | 0.73% |
| TWO SIGMA INVESTMENTS, LP | $1.25M | 0.73% |
| Millennium Management LLC | $1.56M | 0.91% |
| STATE STREET CORPORATION | $1.60M | 0.83% |
| Pathstone Holdings, LLC | $1.81M | 1.19% |
| ADAR1 Capital Management, LLC | $1.88M | 1.23% |
| Alyeska Investment Group, L.P. | $1.98M | 1.30% |
| Hudson Bay Capital Management LP | $2.29M | 1.34% |
| Knollwood Investment Advisory, LLC | $3.44M | 2.25% |
| VANGUARD GROUP INC | $3.49M | 2.29% |
| FMR LLC | $4.28M | 2.80% |
| Franklin Resources, Inc. | $4.86M | 3.19% |
| BlackRock, Inc. | $6.65M | 3.44% |
| Sands Capital Alternatives, LLC | $7.21M | 4.73% |
| RA Capital Management, L.P. | $49.54M | 29.03% |